2nd Quarter - Report

THORN RUN PARTNERS for NOVARTIS CORPORATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Issues related to pharmaceutical pricing and biosimilars. H.R. 19, Lower Costs, More Cures Act of 2019.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
MICHAEL O'SHEA MCCARTHY —
GARY PALMQUIST —
ANDREW ROSENBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 19 (116th)

Medicare/Medicaid MMM

Issues related to Medicare and Medicaid reimbursement of biosimilars and drugs. H.R. 19, Lower Costs, More Cures Act of 2019.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
MICHAEL O'SHEA MCCARTHY —
GARY PALMQUIST —
ANDREW ROSENBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 19 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.